BackFermentalg Overview

Fermentalg EBIT

Fermentalg's EBIT is $-22M, below the Healthcare sector average of $1.1T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$5.10M
↑ 0.47% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$22.23M
↑ 3.8% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Fermentalg (ALGAE.PA) FAQ

The latest EBIT for ALGAE.PA is $-22M as of June 2026. That compares with $-23M in the prior-year period — up 3.8% year over year. That is below the Healthcare sector average of $1.1T. Investors often review this figure alongside Fermentalg's historical trend and sector peers before judging valuation or financial health.

Over the past year, ALGAE.PA's EBIT moved from $-23M to $-22M — a 3.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fermentalg's operating scale or balance-sheet position.

Against Healthcare companies, ALGAE.PA currently prints $-22M for EBIT, while the sector average sits near $1.1T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Fermentalg's growth, margins, and balance sheet.

A EBIT figure of $-22M for ALGAE.PA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.1T. Explore the charts below for those layers of context.

After noting ALGAE.PA's EBIT ($-22M), review year-over-year change from $-23M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers